Robert K. Zeldin - 14 Jan 2024 Form 4 Insider Report for MeiraGTx Holdings plc (MGTX)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Robert J. Wollin, Attorney-in-Fact for Robert K. Zeldin
Issuer symbol
MGTX
Transactions as of
14 Jan 2024
Transactions value $
-$93,848
Form type
4
Filing time
17 Jan 2024, 19:15:35 UTC
Previous filing
18 Jan 2024
Next filing
10 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGTX Ordinary Shares Options Exercise +37,500 +56% 104,480 14 Jan 2024 Direct F1, F2
transaction MGTX Ordinary Shares Tax liability -$93,848 -14,756 -14% $6.36 89,724 14 Jan 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGTX Restricted Share Units Options Exercise $0 -37,500 -50% $0 37,500 14 Jan 2024 Ordinary Shares 37,500 Direct F1, F2
transaction MGTX Stock Option (Right to Buy) Award $0 +30,000 $0 30,000 17 Jan 2024 Ordinary Shares 30,000 $6.16 Direct F4
transaction MGTX Restricted Share Units Award $0 +70,000 $0 70,000 17 Jan 2024 Ordinary Shares 70,000 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vesting of one-quarter of restricted share units granted on January 14, 2021.
F2 Each restricted share unit converts into one ordinary share upon vesting.
F3 Shares withheld for payment of taxes upon vesting of award.
F4 The option vests as to one quarter of the total grant on January 17, 2025 and vests as to the remainder in 36 equal monthly installments thereafter.
F5 Fifty percent of the restricted share unit award will vest on the second anniversary of the grant date and twenty-five percent of the restricted share unit award will vest on each of the third and fourth anniversaries of the grant date.